Technology | March 29, 2013

SonoSite Launches Award-Winning AxoTrack Needle Guidance Technology

“Point-and-shoot” precision, real-time visualization and time-savings tool for ultrasound-guided procedures now available

Fujifil Sonosite Soma Access Systems AxoTrack Needle Guidance Technology

March 29, 2013 — Fujifilm SonoSite Inc. announced the launch of AxoTrack Needle Guidance Technology on select SonoSite Ultrasound Systems. This newly developed product, named by Popular Science Magazine as one of 2012’s best new innovations, is now available for use with SonoSite M-Turbo Ultrasound Systems.

The launch comes with the news that SonoSite has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell specialized ultrasound transducers equipped with AxoTrack Technology engineered by Soma Access Systems LLC.

AxoTrack combines ultrasound with advanced magnetics to provide users with real-time visual updates of needle location as it travels through tissue to the intended target. The easy-to-use, “point-and-shoot” design can save time and may significantly improve procedure outcomes, particularly for vascular access. Pre-existing patient health conditions, like low blood pressure, can increase the risk of complications during these procedures. The ability to simply line up the target line with the vessel and then track the “virtual needle” into the vessel can improve patient safety and the confidence of ultrasound users performing guided procedures.

The AxoTrack System — designed for rapid ease of use — is composed of a specially designed ultrasound transducer from SonoSite and a single-use sterile procedure kit from Soma Access Systems LLC.

“AxoTrack Needle Guidance Technology for SonoSite Systems brings a timely solution to health systems. By reducing vascular access time and enhancing patient safety, AxoTrack can ultimately reduce procedural risks and costs at a time when all of these points really matter to health systems,” said Kevin M. Goodwin, SonoSite’s president and CEO. “It is well recognized that ultrasound visualization improves the accuracy and safety of deep needle-based procedures. AxoTrack takes this to a new level by reducing the spatial coordination required when a needle tip is typically not seen. Now physicians can observe the ‘virtual needle’s’ movement on the screen so they can be more accurate and avoid observed critical structures such as the carotid artery or the lung pleura.

“We are confident this ‘point-and-shoot’ technology will significantly improve outcomes and also make guided procedures far more approachable for new users by addressing the coordination challenges sometimes faced with ultrasound needle guidance.”

An in vitro study using AxoTrack resulted in vascular access procedures that were successful on the first pass and first stick 99.3 percent of the time versus just 37.1 percent of the time when compared to the standard freehand method for ultrasound-guided central venous access.[1]

“For the first time, clinicians have clear sight of needle location as it moves inside the human body,” said Dexter Hagy, president and CEO of Soma Access Systems LLC. “This means fewer passes for difficult-to-reach targets, greater success rates, and increased physician confidence, setting a new standard of care throughout the medical industry.”

After nearly a decade of research and development, Soma Access Systems has refined AxoTrack into a simple and highly effective tool for a variety of ultrasound-guided procedures.

Concludes Goodwin, “The SonoSite collaboration with Soma to bring AxoTrack to market adds a new degree of safety, accuracy, and cost-effectiveness for health systems. Physicians that have seen the technology are amazed, and we have a large SonoSite customer base that has been waiting for it.”

AxoTrack Technology is available in the United States through SonoSite.

For more information: www.sonosite.com, www.SomaAccessSystems.com

Reference:

1 Ferre, R.M., et al. The Use of a Novel Device Improves Real?Time Ultrasound Guided IV Access. Supplement to Annals of Emergency Medicine, Sept. 2010; 56:3:S74.

 

Related Content

Sponsored Content | Videos | Ultrasound Imaging | December 14, 2018
Based on Mindray’s Living Technology, the Resona 7 (Sapphire), ZS3 (Diamond) and TE7 (Crystal) new ultrasound upgrades...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Videos | Ultrasound Imaging | November 28, 2018
This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound.
Clarius Mobile Health Announces Clarius AI Collective Intelligence Ultrasound Platform
News | Ultrasound Imaging | November 21, 2018
Clarius Mobile Health will announce a new collective intelligence ultrasound platform at this year's Radiological...
Civco Medical Solutions Introduces Envision Viral Barrier at RSNA 2018
News | Ultrasound Imaging | November 20, 2018
Civco Medical Solutions will present Envision, the next generation of ultrasound probe covers and scan pads, at the...
Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
SuperSonic Imagine Introduces Aixplorer Mach 30 Ultrasound at The Liver Meeting
Technology | Ultrasound Imaging | November 14, 2018
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company...